What Defines an Adequate Reading with FreeStyle Libre
For FreeStyle Libre to provide clinically useful data, you need a minimum of 14 days of continuous wear with at least 70% active sensor time (approximately 10 days of actual data collection). 1, 2
Minimum Data Requirements
Duration and Active Time:
- Wear the sensor for at least 14 consecutive days to capture reliable glycemic patterns 1, 2
- Maintain ≥70% active CGM time during this period, which translates to approximately 10 days of usable data 1, 2
- This 14-day/70% threshold is the international consensus standard for all CGM systems, including FreeStyle Libre 1
Scanning Frequency:
- Scan the FreeStyle Libre sensor at minimum once every 8 hours to capture complete 24-hour glucose data 3
- More frequent scanning (mean 11.3 scans/day in clinical studies) provides better pattern recognition and improved outcomes 4
- The device stores 8 hours of glucose data; scanning less frequently results in data loss 3
Understanding Sensor Accuracy Across Its Lifespan
Accuracy varies significantly by sensor age:
- Days 0-1: Mean accuracy (MARD) of 14.5% - this is the least accurate period 5
- Days 5-7: Mean accuracy improves to 7.8% - this is the most accurate period 5
- Days 13-14: Mean accuracy returns to 14.7% - accuracy declines again at sensor end-of-life 5
Clinical accuracy remains acceptable throughout:
- Only 1.9% of readings fall into potentially dangerous zones (Clarke error grid zones C, D, or E) during days 0-1 5
- This drops to 0.2% during days 5-7 and 0.4% during days 13-14 5
- Overall MARD of 8.9% makes FreeStyle Libre 3 more accurate than competing systems like Dexcom G7 (13.6% MARD) 6
Essential Metrics for Adequate Assessment
Once you have sufficient data (14 days, ≥70% active time), evaluate these standardized metrics:
Time in Range (TIR):
- Target >70% of readings between 70-180 mg/dL (3.9-10.0 mmol/L) for most adults with diabetes 1, 2
- Each 5% increase in TIR provides clinically significant benefits 1, 2
Time Below Range (TBR):
- Target <4% total time below 70 mg/dL 1, 2
- Specifically: <1% below 54 mg/dL (level 2 hypoglycemia) 1, 2
Time Above Range (TAR):
- Target <25% total time above 180 mg/dL 1, 2
- Minimize time above 250 mg/dL (level 2 hyperglycemia) 1, 2
Glycemic Variability:
- Coefficient of variation (CV) should be ≤36% 1, 2
- Lower CV targets (<33%) provide additional hypoglycemia protection for insulin users 1, 2
Special Population Considerations
For older adults or high-risk individuals, adequate readings require modified targets:
- TIR >50% (≥12 hours/day) in range 70-180 mg/dL 1, 2
- TBR <1% (<15 minutes/day) below 70 mg/dL 1, 2
- TAR <10% (<2 hours, 24 minutes/day) above 250 mg/dL 1, 2
For pregnant individuals:
- Use tighter target range of 63-140 mg/dL (3.5-7.8 mmol/L) 1
- FreeStyle Libre shows good accuracy in gestational diabetes with overall MARD of 14.07% 7
Critical Limitations in Specific Populations
Use with extreme caution or avoid in advanced kidney disease:
- In hemodialysis patients, FreeStyle Libre accuracy drops significantly with MARD of 18.2% overall and 22.8% during dialysis 1
- Only 49-51% of readings fall into acceptable error grid zones A and B in hemodialysis patients 1
- The glucose oxidase-based technology in FreeStyle Libre is susceptible to interference from substances in kidney disease 1
- Do not use FreeStyle Libre in peritoneal dialysis patients - icodextrin interferes with glucose oxidase sensors 1
Common Pitfalls to Avoid
Insufficient data collection:
- Never make treatment decisions based on less than 14 days of data with <70% active time 1, 2
- Gaps in sensor wear reduce clinical value and limit ability to identify patterns 3
Ignoring sensor age effects:
- Be aware that readings during the first 24 hours and last 24 hours are less accurate 5
- Consider inserting a new sensor before removing the old one to avoid data gaps 3
Focusing only on mean glucose:
- Mean glucose alone misses critical information about hypoglycemia and variability 2
- Always evaluate the complete set of 10 standardized CGM metrics 1, 2
Medication and substance interference: